Literature DB >> 7755076

The nutritional status and treatment of patients with hyperemesis gravidarum.

M E van Stuijvenberg1, I Schabort, D Labadarios, J T Nel.   

Abstract

OBJECTIVE: The objective of this study was to evaluate the nutritional status of patients with hyperemesis gravidarum and the effect of a treatment regimen administered during hospitalization. STUDY
DESIGN: This was a descriptive, controlled study of 20 patients with hyperemesis gravidarum whose nutritional status was assessed and compared with that of 20 pregnant, nonvomiting matched controls. Blood nutrient status was reassessed after 10 days of treatment with an intravenous saline solution containing a multivitamin preparation and again at day 20.
RESULTS: Mean dietary intake of most nutrients fell below 50% of the recommended dietary allowances and differed significantly (p < 0.01) from that of controls. More than 60% of the patients had suboptimal biochemical status of thiamine, riboflavin, vitamin B6, vitamin A, and retinol-binding protein. Vitamin C, calcium, albumin, hematocrit, and hemoglobin values were significantly higher in those patients where the duration of vomiting had been longer, suggesting the presence of dehydration. Treatment was associated with cessation of vomiting and improvement in blood nutrient status. Pregnancy outcome was favorable in all patients.
CONCLUSION: The hyperemetic pregnant patient is at nutritional risk; prompt initiation of corrective therapy is recommended.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7755076     DOI: 10.1016/0002-9378(95)90501-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  13 in total

1.  Pregnancy-Related Liver Diseases.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

2.  Dynamic thiol-disulfide homeostasis in hyperemesis gravidarum.

Authors:  M Ergin; B D Cendek; S Neselioglu; A F Avsar; O Erel
Journal:  J Perinatol       Date:  2015-07-09       Impact factor: 2.521

3.  The oxidative stress index increases among patients with hyperemesis gravidarum but not in normal pregnancies.

Authors:  Saynur Yilmaz; A Seval Ozgu-Erdinc; Canan Demirtas; Gulfer Ozturk; Salim Erkaya; Dilek Uygur
Journal:  Redox Rep       Date:  2014-10-18       Impact factor: 4.412

Review 4.  Treatment of nausea and vomiting in pregnancy. When should it be treated and what can be safely taken?

Authors:  C Nelson-Piercy
Journal:  Drug Saf       Date:  1998-08       Impact factor: 5.606

5.  Serum retinol in post-partum mothers and newborns from an impoverished South African community where liver is frequently eaten and vitamin A deficiency is absent.

Authors:  Martha E van Stuijvenberg; Serina E Schoeman; Jana Nel; Carl J Lombard; Muhammad A Dhansay
Journal:  Matern Child Nutr       Date:  2015-11-12       Impact factor: 3.092

Review 6.  GDF15: A Hormone Conveying Somatic Distress to the Brain.

Authors:  Samuel M Lockhart; Vladimir Saudek; Stephen O'Rahilly
Journal:  Endocr Rev       Date:  2020-08-01       Impact factor: 19.871

7.  Norwegian PUQE (Pregnancy-Unique Quantification of Emesis and nausea) identifies patients with hyperemesis gravidarum and poor nutritional intake: a prospective cohort validation study.

Authors:  Elisabeth Birkeland; Guro Stokke; Randi J Tangvik; Erik A Torkildsen; Jane Boateng; Anne L Wollen; Susanne Albrechtsen; Hans Flaatten; Jone Trovik
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

Review 8.  Barriers and Challenges in Hyperemesis Gravidarum Research.

Authors:  Iris J Grooten; Tessa J Roseboom; Rebecca C Painter
Journal:  Nutr Metab Insights       Date:  2016-02-14

Review 9.  Hyperemesis Gravidarum is associated with substantial economic burden in addition to severe physical and psychological suffering.

Authors:  Jone Trovik; Åse Vikanes
Journal:  Isr J Health Policy Res       Date:  2016-10-10

10.  Associations of vomiting and antiemetic use in pregnancy with levels of circulating GDF15 early in the second trimester: A nested case-control study.

Authors:  Clive J Petry; Ken K Ong; Keith A Burling; Peter Barker; Sandra F Goodburn; John R B Perry; Carlo L Acerini; Ieuan A Hughes; Rebecca C Painter; Gijs B Afink; David B Dunger; Stephen O'Rahilly
Journal:  Wellcome Open Res       Date:  2018-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.